Alkem laboratories, providing healthcare beyond boundaries.
Since its inception in 1974, Alkem Laboratories Ltd, has evolved to become a pioneer in the formulations segment of the Indian pharmaceutical industry covering both the acute and chronic therapeutic segments. Alkem is 7th largest pharmaceutical company in India. Its sales and marketing strengths and expertise in brand building are widely recognized as amongst the very best with 14 brands amongst the top 300 brands of the country.
By investing in world class manufacturing facilities, approved by World regulatory authorities including the US FDA, UK MHRA, ANVISA BRAZIL, MCC South Africa and TGA Australia, Alkem currently exports its products to more than 35 countries including the regulated markets of EU, CIS and South East Asia.
Alkem is now venturing into chronic segment in a big way. Two of its major divisions in chronic segment are Alkem Cardiology & Diabetology.
Dedicated division in cardiac care caters to cardiac segment with 180 field force.
Currently the division is operating with 8500 doctors/month with a growth of 42% since 2009.
Dedicated division in diabetes care caters to diabetic segment with 250 field force.
Currently the division is operating with 8000 doctors/month with a growth of 55% since 2009.